IRIS UniCatt

Bellesi, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.859
EU - Europa 3.446
AS - Asia 3.243
SA - Sud America 620
Continente sconosciuto - Info sul continente non disponibili 177
AF - Africa 97
OC - Oceania 7
Totale 12.449
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.662
SG - Singapore 1.374
DE - Germania 1.023
CN - Cina 757
IT - Italia 564
SE - Svezia 495
BR - Brasile 490
VN - Vietnam 420
FR - Francia 306
PL - Polonia 221
GB - Regno Unito 193
FI - Finlandia 155
IN - India 124
UA - Ucraina 118
CA - Canada 113
IE - Irlanda 108
JP - Giappone 91
BD - Bangladesh 90
ID - Indonesia 82
RU - Federazione Russa 67
HK - Hong Kong 55
AR - Argentina 46
MX - Messico 43
NL - Olanda 35
TR - Turchia 33
AT - Austria 29
KR - Corea 28
IQ - Iraq 27
ZA - Sudafrica 23
TW - Taiwan 22
CZ - Repubblica Ceca 21
BE - Belgio 20
CI - Costa d'Avorio 20
VE - Venezuela 19
CO - Colombia 18
EC - Ecuador 18
SA - Arabia Saudita 18
ES - Italia 15
MA - Marocco 14
PK - Pakistan 14
IR - Iran 13
IL - Israele 11
UZ - Uzbekistan 11
CL - Cile 9
JO - Giordania 9
KE - Kenya 9
LT - Lituania 9
CH - Svizzera 8
GR - Grecia 8
HN - Honduras 8
MY - Malesia 8
PH - Filippine 8
PY - Paraguay 8
CR - Costa Rica 7
NP - Nepal 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
JM - Giamaica 6
RO - Romania 6
TN - Tunisia 6
AL - Albania 5
AU - Australia 5
PT - Portogallo 5
RS - Serbia 5
BG - Bulgaria 4
EE - Estonia 4
HU - Ungheria 4
KG - Kirghizistan 4
LB - Libano 4
PE - Perù 4
BB - Barbados 3
CG - Congo 3
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
KH - Cambogia 2
KZ - Kazakistan 2
NI - Nicaragua 2
PA - Panama 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 12.257
Salva come PNG Salva come JPEG
Città #
Singapore 803
Ashburn 481
Chandler 458
San Jose 381
Warsaw 201
Munich 172
Beijing 152
New York 142
Ho Chi Minh City 121
The Dalles 121
Fairfield 116
Rome 114
Hanoi 110
Los Angeles 108
Dublin 104
Hefei 92
Helsinki 89
Houston 88
Jacksonville 87
San Mateo 75
Lauterbourg 73
Dallas 72
Jakarta 72
Tokyo 71
Wilmington 65
Dearborn 60
Milan 60
Nanjing 60
Ann Arbor 58
Frankfurt am Main 57
Seattle 54
Woodbridge 53
Nürnberg 49
Marseille 48
Hong Kong 47
Boston 46
Chicago 44
Moscow 43
Santa Clara 43
São Paulo 41
Phoenix 39
Cattolica 37
Bremen 36
Lancaster 36
Buffalo 34
Boardman 33
Princeton 33
Montreal 32
London 30
Atlanta 28
Council Bluffs 27
Da Nang 27
Denver 27
Nanchang 27
Seoul 27
Nuremberg 26
Orem 26
Guangzhou 24
Kent 24
Redwood City 24
Hyderabad 23
Toronto 23
Brooklyn 22
Mexico City 22
San Francisco 22
Abidjan 20
Cambridge 20
Haiphong 20
Lappeenranta 20
Amsterdam 19
Lawrence 19
Tianjin 19
Brussels 18
Naples 18
Paris 18
Rio de Janeiro 18
Brno 17
Hangzhou 17
Turku 17
Johannesburg 16
Shanghai 16
Vienna 16
Belo Horizonte 15
Leawood 15
Poplar 15
St Louis 14
Washington 14
Chennai 13
Stockholm 13
Baghdad 12
Düsseldorf 12
Fremont 12
Manchester 12
Florence 11
Wroclaw 11
Changsha 10
Dhaka 10
Izmir 10
Kunming 10
Memphis 10
Totale 6.367
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 441
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 357
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 334
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 296
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 274
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 270
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 249
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 245
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 238
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 236
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 231
Correlation between paraproteinaemia and viral reactivation after allo-SCT 230
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 209
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 202
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 197
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 195
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 195
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 189
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 189
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 189
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 188
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 185
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 185
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 182
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 180
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 179
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 179
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 178
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 172
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 165
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 162
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 160
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 156
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 156
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 153
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 153
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 151
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 148
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 144
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 143
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 142
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 141
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 141
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 140
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 139
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 134
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 123
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 122
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 121
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 119
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 118
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 114
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 113
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 113
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 113
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 112
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 111
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 110
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 110
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 109
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 109
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 108
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 105
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 99
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 91
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results 91
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 90
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 87
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 85
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 85
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 85
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 80
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 78
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 77
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 68
External validation of the accuracy of 'CLLflow score' 68
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 62
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements 52
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 40
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 35
CD19 expression on bone marrow hematogones and blasts following anti-CD19 therapy in B-ALL: a descriptive single-center analysis 23
Totale 12.449
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.297
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022521 0 0 7 14 33 20 18 76 32 64 113 144
2022/20231.323 193 185 81 222 87 132 91 94 134 43 44 17
2023/2024721 32 176 28 41 26 97 54 53 9 28 84 93
2024/20251.988 64 59 116 100 165 107 144 88 237 183 398 327
2025/20264.400 570 155 256 493 773 206 871 225 262 283 133 173
2026/2027980 270 444 266 0 0 0 0 0 0 0 0 0
Totale 12.449